Search

Your search keyword '"Dai, Xinyue"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Dai, Xinyue" Remove constraint Author: "Dai, Xinyue" Database Unpaywall Remove constraint Database: Unpaywall
134 results on '"Dai, Xinyue"'

Search Results

3. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial

4. Sex-specific impact on disease outcome and the mutational landscape in essential thrombocythemia: A retrospective cohort study

5. Kabuki syndrome complicated by severe immune thrombocytopenia and autoimmune thyroiditis: Identification of a novel pathogenic mutation

8. Genetically determined telomere length and risk for haematologic diseases: results from large prospective cohorts and Mendelian Randomization analysis

9. Metabolomics profile and machine learning prediction of treatment responses in immune thrombocytopenia: A prospective cohort study

13. Genetically Determined Telomere Length and Risk for Haematologic Diseases: Results from Large Prospective Cohorts and Mendelian Randomization Analysis

15. Acquired hemophilia A: a single-center study of 165 patients

17. Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial

18. Single‐dose rituximab plus glucocorticoid versus cyclophosphamide plus glucocorticoid in patients with newly diagnosed acquired hemophilia A: A multicenter, open‐label, randomized noninferiority trial

27. Increased reactive oxygen species lead to overactivation of platelets in essential thrombocythemia

30. Oxygen-vacancy-rich molybdenum carbide MXene nanonetworks for ultrasound-triggered and capturing-enhanced sonocatalytic bacteria eradication

39. Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors

40. Single Atom‐Doped Nanosonosensitizers for Mutually Optimized Sono/Chemo‐Nanodynamic Therapy of Triple Negative Breast Cancer

47. Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

Catalog

Books, media, physical & digital resources